Efficacy of Tezepelumab in Peanut Allergy

(

ZENITH

)

ITN Protocol #:

ITN097AD

Branded Name:

ZENITH

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Allergy & Asthma

Current Status:

Development

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

Efficacy of Tezepelumab in Peanut Allergy: a Double-Blind, Randomized, Placebo-controlled Trial

Clinical Operations Manager

ITN Biologist

ITN Biostat

ITN Clinical Trial Physician

NIAID Project Manager

NIAID Regulator Officer

Rho Data Manager

Rho Scientist

PPD Lead Monitor

Study Personnel:

Protocol Chair

Edwin Kim edwinkim@med.unc.edu

Work:

919-962-4409

Protocol Chair

Sarita Patil, MD sarita.patil@mgh.harvard.edu

Work:

Protocol Chair

MacKenzie Cox mcox@immunetolerance.org

Work:

415-939-7249

Protocol Chair

Carolyn Baloh, MD cbaloh@immunetolerance.org

Work:

412-508-5216

Protocol Chair

Michelle Huffaker, MD mhuffaker@immunetolerance.org

Work:

415-610-8370

Protocol Chair

Paul Price, PhD paul.price@nih.gov

Work:

301-761-7835

Protocol Chair

Lars Dunaway, PhD Lars_Dunaway@rhoworld.com

Work:

(919) 595-6382

Admin Links

Shortcuts

ITN Documents

Links